08:00 , Dec 17, 2012 |  BioCentury  |  Emerging Company Profile

Alzinova: Freezing out AD

Alzinova AB is developing an Alzheimer's disease vaccine that uses an engineered beta amyloid mimic to raise an immune response against highly toxic AD-associated beta amyloid oligomers. The approach could yield a more potent protective...